Tirzepatide SURMOUNT-MAINTAIN trial evaluates continued or reduced dosing for long-term obesity weight maintenance.
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.
Abstract
Tirzepatide's SURMOUNT-MAINTAIN trial investigates the efficacy and safety of continued or reduced dosing for long-term weight maintenance in adults with obesity.